COMMENTARY FROM MANAGEMENT Merko Ehitus posted revenue of EUR 160.4 million and net profit of EUR 19.9 million in Q4 of 2024. The respective figures for the entire year 2024 were EUR 539 million and ...
Joseph Del Preto, the Chief Financial Officer and Treasurer of Sprout Social, Inc. (NASDAQ:SPT), a $1.89 billion market cap company currently trading at $32.60, recently sold 1,500 shares of the ...
AirBaltic, based in Riga, is the largest airline in the Baltic States. It flies to more than 70 destinations from its Riga hub and has a standard fleet of 50 Airbus A220s. The Latvian airline has ...
DURHAM, N.C., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of ...
Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that ...
Maze Therapeutics begins Phase 2 trial for kidney disease drug By Investing.com - Feb 07, 2025 SOUTH SAN FRANCISCO – Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical ...
Tech stocks led the market on Wednesday as Netflix (NFLX) stock surged to a record, while President Donald Trump's boost to AI demand hopes outweighed fresh tariff worries. Meanwhile, the Dow ...
Nvidia (NASDAQ: NVDA) stock posted significant gains in Wednesday's trading following bullish artificial intelligence (AI) news. The company's share price closed out the day up 4.4% amid the ...
Shares of Grail, a medical technology company, jumped 20% Wednesday to lead Nasdaq 100 gainers. Grail spun off from Illumina last year, and is developing a number of early detection cancer ...
The Nasdaq 100 Index has nearly doubled since the start of 2023, adding $14 trillion in value in the process. Evercore ISI’s Rich Ross is prepared for that rally to continue, shrugging off fears ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results